Ioannis A. Voutsadakis

Oncology

200 Hawkins Dr
Iowa City, IA 52242

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 187 publications

Epigenetics and DNA Base Substitutions of Epstein-Barr Virus (EBV)-Related Gastric Cancers: Implications for Targeted Therapies.

Epigenetics and DNA Base Substitutions of Epstein-Barr Virus (EBV)-Related Gastric Cancers: Implications for Targeted Therapies.

Journal: Genes

Published: May 24, 2026

Dihydropyrimidine dehydrogenase (DPYD) genetic testing and treatment with 5-fluoropyrimidines in cancer patients: prevalence of variants with decreased activity and chemotherapy outcomes.

Dihydropyrimidine dehydrogenase (DPYD) genetic testing and treatment with 5-fluoropyrimidines in cancer patients: prevalence of variants with decreased activity and chemotherapy outcomes.

Journal: Pharmacogenomics

Published: March 09, 2026

Genomics of gastroesophageal junction adenocarcinomas and the Siewert classification.

Genomics of gastroesophageal junction adenocarcinomas and the Siewert classification.

Journal: Translational gastroenterology and hepatology

Published: February 10, 2026

The Regulation of p53 by Ubiquitination and Implications for Therapeutic Targeting in Colorectal Cancer.

The Regulation of p53 by Ubiquitination and Implications for Therapeutic Targeting in Colorectal Cancer.

Journal: Genes

Published: January 23, 2026

Recent advances in chemotherapy and targeted therapies for breast sarcoma.

Recent advances in chemotherapy and targeted therapies for breast sarcoma.

Journal: Expert review of anticancer therapy

Published: December 24, 2025

The Landscape of Genomic Alterations in Receptor Tyrosine Kinase Pathways in Biliary Cancers: Implications for Targeted Therapies.

The Landscape of Genomic Alterations in Receptor Tyrosine Kinase Pathways in Biliary Cancers: Implications for Targeted Therapies.

Journal: Journal of gastrointestinal cancer

Published: October 13, 2025

The thyroid endocrine axis in breast cancer pathophysiology and prognosis.

The thyroid endocrine axis in breast cancer pathophysiology and prognosis.

Journal: Vitamins and hormones

Published: August 14, 2025

From PIK3CA Mutations to Rational PI3K Inhibition for the Treatment of Colorectal Cancer.

From PIK3CA Mutations to Rational PI3K Inhibition for the Treatment of Colorectal Cancer.

Journal: Molecular diagnosis & therapy

Published: July 08, 2025

Mismatch repair (MMR) assay uptake and use in early colorectal cancer patients with MMR-deficient and MMR-proficient tumors.

Mismatch repair (MMR) assay uptake and use in early colorectal cancer patients with MMR-deficient and MMR-proficient tumors.

Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research

Published: July 03, 2025

ETS Family Transcription Factors in Gastric Cancer and the Role of ELF3 in the Core Metaplasia Transcription Factor Network.

ETS Family Transcription Factors in Gastric Cancer and the Role of ELF3 in the Core Metaplasia Transcription Factor Network.

Journal: Oncology research

Published: June 18, 2025

Clinical and Pathological Features and Survival Outcomes of Breast Cancers with Intermediate ER Expression.

Clinical and Pathological Features and Survival Outcomes of Breast Cancers with Intermediate ER Expression.

Journal: Cancers

Published: May 22, 2025

Biomarkers of primary and secondary resistance to cyclin dependent kinases 4 and 6 inhibitors in metastatic estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer: a narrative review.

Biomarkers of primary and secondary resistance to cyclin dependent kinases 4 and 6 inhibitors in metastatic estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer: a narrative review.

Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer

Published: April 30, 2025

Showing 1-12 of 187

Last Updated: 09/26/2026